Cyclo Therapeutics Stock (NASDAQ: CYTH) stock price, news, charts, stock research, profile.
Open | $1.230 |
Close | $1.300 |
Volume / Avg. | 21.098K / 108.049K |
Day Range | 1.220 - 1.310 |
52 Wk Range | 0.680 - 2.570 |
Market Cap | $35.898M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 0.18% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cyclo Therapeutics (NASDAQ: CYTH) through any online brokerage.
Other companies in Cyclo Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP) and OncoCyte (NASDAQ:OCX).
The latest price target for Cyclo Therapeutics (NASDAQ: CYTH) was reported by Ascendiant Capital on Monday, April 22, 2024. The analyst firm set a price target for 2.60 expecting CYTH to rise to within 12 months (a possible 107.98% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Cyclo Therapeutics (NASDAQ: CYTH) is $1.2501 last updated April 24, 2024 at 4:39 PM EDT.
There are no upcoming dividends for Cyclo Therapeutics.
Cyclo Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Cyclo Therapeutics.
Cyclo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.